Medicine
Alprazolam 0.25 mg tablet
Alprazolam 0.25 mg tablet is a generic prescription medicine for oral use, made by 19 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at controlled room temperature 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Alprazolam
- Brand
- Sold under the generic name
- Strength
- 0.25 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 1000 tablets and 84 more
- Manufacturers
- Aurobindo PharmaIndiaNatco PharmaIndiaUnichem LaboratoriesIndiaAphena Pharma Solutions - TennesseeActavis PharmaANI PharmaceuticalsMylan PharmaceuticalsSandozNuCare Pharmaceuticals,Inc19 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at controlled room temperature 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CIV
- ATC code
- N05BA12 Alprazolam
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 16 October 1981
- Identifiers
- RxCUI 308047, 197321, 197322 +1DailyMed set ID 8ca8e0fc-6c3d-48d4-ad04-708182b45350, 3c0cb60f-1c3a-48a6-ad16-f14351548412, 447efe78-3696-481c-bbae-23199a39ec94 +24NDC 71335-2133, 50090-1864, 63187-916 +24Application ANDA074342, ANDA074112, NDA018276 +4
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 19 labelers. The register lists 87 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 65862-676-01 | Aurobindo PharmaIndia | 31 July 2015 |
| 500 tablet in 1 bottle | 65862-676-05 | Aurobindo PharmaIndia | 31 July 2015 |
| 1000 tablet in 1 bottle | 65862-676-99 | Aurobindo PharmaIndia | 31 July 2015 |
| 100 tablet in 1 bottle | 69339-199-01 | Natco PharmaIndia | 28 July 2023 |
| 500 tablet in 1 bottle | 69339-199-05 | Natco PharmaIndia | 28 July 2023 |
| 1000 tablet in 1 bottle | 69339-199-10 | Natco PharmaIndia | 28 July 2023 |
| 100 tablet in 1 bottle | 29300-360-01 | Unichem LaboratoriesIndia | 2 November 2026 |
| 500 tablet in 1 bottle | 29300-360-05 | Unichem LaboratoriesIndia | 2 November 2026 |
| 1000 tablet in 1 bottle | 29300-360-10 | Unichem LaboratoriesIndia | 2 November 2026 |
| 100 tablet in 1 bottle | 0228-2027-10 | Actavis Pharma | 1 October 1993 |
| 500 tablet in 1 bottle | 0228-2027-50 | Actavis Pharma | 1 October 1993 |
| 1000 tablet in 1 bottle | 0228-2027-96 | Actavis Pharma | 1 October 1993 |
| 100 tablet in 1 bottle | 70954-508-10 | ANI Pharmaceuticals | 11 May 2021 |
| 500 tablet in 1 bottle | 70954-508-20 | ANI Pharmaceuticals | 11 May 2021 |
| 1000 tablet in 1 bottle | 70954-508-30 | ANI Pharmaceuticals | 11 May 2021 |
| 100 tablet in 1 bottle | 59762-3719-1 | Mylan Pharmaceuticals | 16 October 1981 |
| 500 tablet in 1 bottle | 59762-3719-3 | Mylan Pharmaceuticals | 16 October 1981 |
| 1000 tablet in 1 bottle | 59762-3719-4 | Mylan Pharmaceuticals | 16 October 1981 |
| 100 tablet in 1 bottle | 0781-1061-01 | Sandoz | 29 December 1995 |
| 500 tablet in 1 bottle | 0781-1061-05 | Sandoz | 29 December 1995 |
| 1000 tablet in 1 bottle | 0781-1061-10 | Sandoz | 29 December 1995 |
| 15 tablet in 1 bottle | 67544-414-15 | Aphena Pharma Solutions - Tennessee | 16 June 2006 |
| 30 tablet in 1 bottle | 67544-414-30 | Aphena Pharma Solutions - Tennessee | 30 June 2005 |
| 45 tablet in 1 bottle | 67544-414-45 | Aphena Pharma Solutions - Tennessee | 1 June 2006 |
| 60 tablet in 1 bottle | 67544-414-53 | Aphena Pharma Solutions - Tennessee | 30 June 2005 |
| 90 tablet in 1 bottle | 67544-414-60 | Aphena Pharma Solutions - Tennessee | 23 June 2005 |
| 120 tablet in 1 bottle | 67544-414-70 | Aphena Pharma Solutions - Tennessee | 7 September 2005 |
| 180 tablet in 1 bottle | 67544-414-80 | Aphena Pharma Solutions - Tennessee | 22 February 2008 |
| 30 tablet in 1 bottle | 71610-112-30 | Aphena Pharma Solutions - Tennessee | 6 August 2018 |
| 60 tablet in 1 bottle | 71610-112-53 | Aphena Pharma Solutions - Tennessee | 6 August 2018 |
| 90 tablet in 1 bottle | 71610-112-60 | Aphena Pharma Solutions - Tennessee | 6 August 2018 |
| 120 tablet in 1 bottle | 71610-112-70 | Aphena Pharma Solutions - Tennessee | 6 August 2018 |
| 15 tablet in 1 bottle | 71610-696-15 | Aphena Pharma Solutions - Tennessee | 20 March 2023 |
| 30 tablet in 1 bottle | 71610-696-30 | Aphena Pharma Solutions - Tennessee | 20 March 2023 |
| 45 tablet in 1 bottle | 71610-696-45 | Aphena Pharma Solutions - Tennessee | 20 March 2023 |
| 60 tablet in 1 bottle | 71610-696-53 | Aphena Pharma Solutions - Tennessee | 20 March 2023 |
| 90 tablet in 1 bottle | 71610-696-60 | Aphena Pharma Solutions - Tennessee | 20 March 2023 |
| 120 tablet in 1 bottle | 71610-696-70 | Aphena Pharma Solutions - Tennessee | 20 March 2023 |
| 10 tablet in 1 bottle | 68071-2292-1 | NuCare Pharmaceuticals,Inc | 16 November 2020 |
| 4 tablet in 1 bottle | 68071-3481-4 | NuCare Pharmaceuticals,Inc | 9 August 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 16 October 1981 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Alprazolam 0.25 mg tablet.
Other strengths and forms of Alprazolam
Clinical summary
Alprazolam is a benzodiazepine indicated for the acute treatment of generalized anxiety disorder (GAD) in adults, among other approved uses. It is available as tablets, extended-release tablets and orally disintegrating tablets. MedsAcross supplies Alprazolam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AlprazolamFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Alprazolam prescribing information (Mylan Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Alprazolam 0.25 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.